To determine whether TAZ enhances the tumor progress of GBM cells by accelerating cell proliferation, a widely known cell proliferation marker-Ki67, was tested in the tumor xenografts tissues by immunohistochemical staining. The gene discussed is MKI67; the disease is neoplasm.